TRAITEMENT DU DIABETE

European patent · EP0762890 · Deleted

Register entry

Publication number
EP0762890
Application number
EP95917874
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 12, 1995
Published
Mar 19, 1997
Granted
Jul 26, 2000
Deleted
Jul 26, 2000
Reason
Revoked in opposition
IPC classes
A61K 38/26 (2006.01)
Priority
GB 9409496 12.05.1994
PCT application
PCT/CA1995/000287 12.05.1995
PCT publication
WO1995/031214 23.11.1995
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 25, 2024

    Change

    Published in Swissreg on 25.06.2024

  2. Jun 25, 2024

    Change

    Published in Swissreg on 25.06.2024

  3. Jan 14, 2005

    Deleted, fee unpaid

    Published in +pat+ No 1 in 2005

  4. Oct 13, 2000

    Agent entered

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in PIDTJ No 19 in 2000

  5. Jul 31, 2000

    Granted

    Published in PIDTJ No 14 in 2000

Parties

Holder

Amylin Pharmaceuticals, Inc.

AMYLIN PHARMACEUTICALS, INC.

9373 Towne Centre Drive, San Diego, California 92121, US

Agent

Patentanwälte Schaad, Balass, Menzl & Partner AG

Dufourstrasse 101, 8034 Zürich

Inventor

DUPRE, John

London, Ontario N6A 2E2, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.